Shanghai Sanyou Medical Co., Ltd (SHA:688085)

Shanghai Sanyou Medical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	50.73	63.1	11.47	95.58	190.82	186.37
Depreciation & Amortization	37.22	37.09	38.35	30.03	18.99	15.49
Other Amortization	24.69	22.6	23.07	24.35	15.23	12.65
Loss (Gain) From Sale of Assets	0.04	0.07	-6.43	0.05	0.06	-0.04
Asset Writedown & Restructuring Costs	10.41	13.96	10.22	-	-	2.83
Loss (Gain) From Sale of Investments	4	2.45	-5.68	6.89	-41.59	-53.77
Provision & Write-off of Bad Debts	2.54	2.54	1.05	-8.76	2.79	-
Other Operating Activities	5.81	-1.93	18.56	29.58	20.56	9.11
Change in Accounts Receivable	-19.06	-12.91	2.06	214.68	-39.32	-70.1
Change in Inventory	-53.47	-61.1	-68.15	-73.57	-55.03	-40.6
Change in Accounts Payable	1.71	-5.79	-25.46	-65.73	39.84	75.88
Change in Other Net Operating Assets	27.47	12.05	7.87	-0.23	0.77	4.04
Operating Cash Flow	84.1	67.99	10.96	267.43	155.97	144.92
Operating Cash Flow Growth	358.89%	520.07%	-95.90%	71.46%	7.63%	86.94%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-33.98	-28.91	-37.44	-25.94	-138.2	-91.66
Sale of Property, Plant & Equipment	-0.14	0.53	5.42	0.15	-	0.37
Cash Acquisitions	-	-	-	-30.38	-0.97	-268.48
Investment in Securities	-86.51	-131.47	-204.34	123.88	-25.86	356
Other Investing Activities	2.62	2.45	2.76	1.08	8.88	16.14
Investing Cash Flow	-118.01	-157.4	-233.59	68.8	-156.15	12.36

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	19.71	45.14	-	-	-
Long-Term Debt Repaid	-	-32.33	-51.94	-3.55	-4.52	-1.46
Net Debt Issued (Repaid)	-16.04	-12.62	-6.8	-3.55	-4.52	-1.46
Issuance of Common Stock	-	205.3	-	-	-	-
Common Dividends Paid	-8.12	-2.14	-22.65	-19.2	-37.37	-35.86
Other Financing Activities	30.9	-171.93	1.28	-	-	-
Financing Cash Flow	6.74	18.61	-28.17	-22.75	-41.9	-37.32

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-1.3	3.36	-0.47	0.44	0.19	-0.1
Net Cash Flow	-28.47	-67.44	-251.26	313.92	-41.88	119.85

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	50.12	39.08	-26.47	241.5	17.78	53.26
Free Cash Flow Growth	-	-	-	1258.46%	-66.62%	13.15%
Free Cash Flow Margin	8.84%	7.20%	-5.84%	52.45%	2.74%	8.98%
Free Cash Flow Per Share	0.14	0.11	-0.08	0.73	0.05	0.16
Levered Free Cash Flow	-174.53	19.54	-34.39	228.66	-54.62	41.23
Unlevered Free Cash Flow	-173.73	20.34	-33.66	228.83	-54.49	41.33

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	47.61	41.83	19.75	71.76	119.5	69.84
Change in Working Capital	-51.36	-71.89	-79.63	89.71	-50.88	-34.95

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error